INTRODUCTION
Acute dental pain can be very severe, leading to significant patient distress. Sufferers may consume large quanti ties of over the counter (OTC) analgesics while waiting for appointments with general dental services, assuming they have access to a dentist at all. Paraceta mol is easily available over the counter and not surprisingly is popular with those who are seeking symptom relief.
Paracetamol is a recognised cause of overdose that can result in a slow unpleasant death due to liver necrosis. It is often used in deliberate suicide 1* SHO Oral and Maxillofacial Surgery, 2 Locum Consult ant Oral Surgeon, 3 Locum Consultant Oral Surgeon, 4 attempts; accounting for 9% of drug related suicides. 1 In response to anal gesic related mortality in the UK, leg islation was introduced in 1998 to limit analgesic pack sizes. This resulted in a reduction in paracetamol related sui cidal deaths by 22%, in the year after the change in legislation. 2 However even with these changes it is still possible to obtain large quantities of paracetamol. It is unsurprising that patients may be unaware of the maximum dose of para cetamol and the associated dangers of accidental over-consumption.
A search of the literature has revealed only a few reports of paracetamol over doses in patients attempting to relieve dental pain. One report describes an unintentional paracetamol overdose, secondary to acute dental pain for which the patient did not require addi tional medical treatment 3 while another describes a patient with liver failure sec ondary to paracetamol overdose arising from an attempt to relieve the symptoms of pericoronitis. 4 Thus we present two cases of unin tentional overdose of paracetamol in patients suffering acute dental pain, presenting over a one month period to an A&E department of a district general hospital. Both cases required treatment with paracetamol antidote.
CASE REPORT 1
A 20-year-old female student presented to the A&E department at 11pm over the Christmas period, complaining of tooth ache even though she had an appoint ment with her general dental practitioner (GDP) the following day. She admitted that in her efforts to ease her toothache, she had taken 16 paracetamol, 16 ibu profen and two co-codamol (combined paracetamol and codeine phosphate doses) during the preceding 24 hours. There was no reported intent of self harm. Based on her weight of 40 kg, this equated to a consumed paracetamol dose of 225 mg/kg and 80 mg/kg of ibuprofen, taken as staggered doses. Following con sultation with Toxbase (National Poisons Information Database), N acetyl-cysteine (NAC) treatment (Parvolex®) was insti gated to treat the threat posed by the paracetamol dosage. Blood investiga tions were performed and clinical obser vations noted. No action was required for the quantities of ibuprofen taken.
As the patient was still in substantial pain the on-call SHO in oral and maxillo facial surgery was requested to assess the patient. She reported a 24 hour history of unbearable toothache from the lower left quadrant. The patient was normally fi t and well and clinical and radiographic exami nation revealed a large carious cavity in the lower left second permanent molar. A diagnosis of irreversible pulpitis was made and an inferior alveolar nerve block of 2% lidocaine with 1:80,000 adrenaline and 0.25 % bupivicaine was given. This pro vided immediate pain relief. The patient was admitted under the medical team for assessment of any potential liver damage. A full blood count, urea and electrolyte assay, liver function tests, coagulation screen, international normalised ratio (INR) and paracetamol levels were recorded as a baseline. Paracetamol levels were monitored regularly and shown to decrease from 35.5 µg/ml to 12 µg/ml over two hours of Parvolex® treatment.
The patient's dental pain returned the following day and so with the agreement of the medical team she was taken to the oral and maxillofacial department for extirpation of the pulp tissue and dress ing of the lower left second permanent molar. She was advised to return to her GDP for continued treatment.
Repeat blood investigations were nor mal and her INR was 1.0 suggesting that liver damage was unlikely. Her dental pain had subsided enough for her to be discharged from the hospital but with arrangements for follow-up.
CASE REPORT 2
A 20-year-old male attended the A&E department, at 10.56pm one midweek evening, complaining of toothache from which he had been suffering for some months. He was not registered with a dentist. He informed the staff that he had taken 10 paracetamol tablets that night. When called by the doctor he had left the department. The patient returned four hours later by ambulance by which time he had consumed a further 10 paraceta mol tablets and was vomiting repeatedly. At this point he admitted to the casualty doctor to taking approximately 60 tab lets over the last three days. This was calculated as approximately 428 mg/kg as a staggered dose.
The patient was usually fit and well and there was no intent on self harm. On examination the patient was in distress, complaining of abdominal pain with tenderness of the upper right quadrant and vomiting bile products. The abdo men was soft on palpation but with some evidence of guarding. A provisional diagnosis of staggered dose paracetamol overdose and possible liver failure was made. The paracetamol antidote (NAC, Parvolex®) was administered along with opioid analgesia. Appropriate baseline blood investigations were carried out which comprised full blood count, urea and electrolytes assay, liver function tests, INR, arterial blood gases, plasma paracetamol levels. The patient was transferred to the medical ward.
Blood investigations taken on presenta tion showed elevation of white cell count suggestive of active infection, elevation of The on-call SHO in oral and maxillo facial surgery was called to assess the dental pain. Clinical and radiographic examination revealed a grossly cari ous upper right first permanent molar with buccal sulcus tenderness consistent with a developing dentoalveolar abscess. The tooth was extracted 24 hours after admission, after liver damage and asso ciated increased bleeding tendency could be ruled out by repeat blood inves tigation. The patient was discharged the next day as INR and LFT had been stable for 48 hours and the paracetamol plasma concentration had dropped from 25.9 µg/ml on admission to < 10.0 µg/ml 24 hours later.
DISCUSSION
These two cases demonstrate the poten tial for serious health problems in patients self medicating OTC analgesics in an attempt to gain relief from dental pain. It is essential for patient welfare that they have access to medical advice to guide them through this stage until definitive care can be arranged. The fi rst of the patients presented was registered with a dentist but was unable to secure an appointment until the following day. The second of the patients presented was not registered with a dentist at all, which raises intriguing issues in these turbu lent times of diminishing numbers of NHS dentists and the nationwide prob lem of access to dental care. It may be that both these patients were unaware of the risks of excessive paracetamol con sumption, something shown in previous papers, 3 making guidance from health care professionals paramount.
Both these patients had ingested suf ficient doses of paracetamol to require medical care. The issue was detected by careful questioning in the casualty department but the lessons to be learned from these clinical episodes have special relevance to all in the dental profession. Primary among these is: the need to recognise at risk patients from the his tory and clinical examination and the pharmacology behind this effective but potentially hazardous drug.
Paracetamol (acetaminophen in the USA) is a very effective over the coun ter analgesic for the treatment of den tal pain. It is an alanine derivative with primarily analgesic and antipyretic properties. The drug is well absorbed from the small intestine after oral inges tion with peak plasma concentrations within 60 minutes and a half life of two hours. 5 Paracetamol is metabolised in the liver by a process called conjugation. Its mechanism of action is unclear but it is a less potent inhibitor of the cyclo oxygenase system (COX) than conven tional non-steroidal anti-infl ammatories (NSAIDS), accounting for its minimal anti-inflammatory effect. It is active at inhibiting brain prostaglandin (PGE1 and PGE2) synthesis responsible for the analgesic effect. Inhibition of PG syn thesis also occurs within the hypothala mus resulting in the antipyretic effects.
Side effects of paracetamol overdose include skin rashes and white blood cell disorders, but more seriously, hepato toxicity of overdose. At normal doses paracetamol is broken down in the liver to glucuronide and sulphate conjugates. A small proportion is also converted by the microsomal p450 oxidation chain to a reactive metabolite N-acetyl-p benzoquinone imine (NAPBQI). This metabolite is conjugated with glutath ione to form cysteine and mercaptur ate conjugates. In overdose, available supplies of glutathione are exhausted and NAPBQI accumulates contribut ing to hepatocellular necrosis. N-acetyl cysteine supplements, eg Parvolex® acts as a source of thiol groups that may be used in the synthesis of addi tional glutathione, hopefully reducing hepatocellular damage.
As little as 10-15 g (20-30 tablets) or 150 mg/kg of paracetamol taken within 24 hours may cause severe hepatocellu lar necrosis, acute liver damage and less frequently renal tubular necrosis. 6 Many patients suffering from acute dental pain may be unaware of the number of analgesic preparations they have consumed in their pursuit of symp tom relief. The problem of overdose is compounded by the fact that a signifi cant number of cases exhibit no obvious signs during the first 24 hours following inges tion. It is therefore important that both primary care and hospital practitioners are aware of the signs and symptoms that may indicate a patient is at risk of a para cetamol overdose (Table 1) . Since many of the early signs and symptoms are non-specific a thorough drug history is essential for anyone self medicating with dental pain so that an urgent transfer to a medical unit can be made.
Early treatment of overdose is essen tial. Gastric lavage will prevent further absorption if provided within the fi rst hour of ingestion. (Fig. 1) . This also applies to those who have consumed a single large dose at a known time. This treatment should continue until plasma-paraceta mol concentration signifi cantly reduces. This concentration can be plotted on a paracetamol treatment graph. Those with plasma-paracetamol concentration above the treatment line receive n-acetyl cysteine. Minimal hepatic impairment can be anticipated when the plasma con centration is less than 120 µgml -1 at four hours or 30 µgml -1 at 12 hours. Plasma paracetamol concentration may be dif ficult to interpret when paracetamol has been ingested over several hours. If there is doubt patients should receive the antidote.
N-acetylcysteine is given intrave nously, initially as 150 mg/kg in 200 ml of 5% dextrose over 15 minutes, then 50 mg/kg in 500 ml of 5% dextrose over four hours then 100mg/kg in 1000ml of 5% dextrose over 16 hours. The overall management of the patients can be sum marised as follows, adapted from the NPIS guidelines: Figure  1 is meaningless as time of ingestion is continuous 8. Those who have received NAC can be discharged 24 hours after last ingestion provided they have com pleted the course and are asymp tomatic and INR, ALT and plasma creatinine are normal.
Patients suffering from dental pain are more likely to consume high levels of paracetamol as a staggered dose rather than single large doses with intention to cause self harm. The guidelines show that in these patients NAC treatment should be started immediately as the graph of plasma paracetamol concentra tion by time is meaningless.
These two cases highlight the benefi ts of dentists educating their patients on the safe use of analgesia, especially para cetamol, but also emphasises the need for such health professionals to be totally familiar with the drugs their patients are taking. Many over the counter anal gesics (OTC) contain paracetamol such as Panadol® or paediatric medications such as Calpol® and Disprol®. Parents may be unaware of the sources of paracetamol that may result in accidental overdose of their child. Several OTC medications are compound in nature combining opi oid analgesia with paracetamol such as Co-codamol in Solpadol® and Kapake®. The consumption of additional para cetamol with these medications could be catastrophic. It is also important to bear in mind that several commonly used medications such as 'cold and fl u' tablets contain significant amounts of paracetamol, as much as 1000 mg eg Lemsip Max cold and fl u®. Likewise anti-migraine tablets such as Mig raleve® combine paracetamol with buclizine hydrochloride. Unless patients carefully examine the packaging of these OTC medications they may be unaware of this important fact. If such patients suffer from dental pain and take additional paracetamol they may unknowingly approach toxic doses. Dentists therefore need to be aware of all possible sources of paracetamol their patients may be taking, prior to advising on appropriate analgesia for dental pain.
